Two Interforaminal Implants in an Immediate or Delayed Loading Protocol for the Elderly
NCT ID: NCT04292132
Last Updated: 2020-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2012-07-02
2018-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In-patient Comparison of Immediately Loaded and Non-loaded Submerged and Transgingival Healed Implants Within 4 Months
NCT06408506
Immediate Loading of Implants in the Partially or Completely Edentulous Jaw
NCT02661412
Evaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface
NCT00782171
A Clinical Evaluation of NobelProcera Implant Bar Overdenture
NCT01720420
Long-term Study in Early Loaded Hydrophilic Surface Implants
NCT06138392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Especially for gerontoprosthetics, the Locator® abutment system offers the possibility of a minimally invasive retention of prosthetic total restorations of edentulous mandibles. The reduced number of 2 interforaminal implants is intended to ensure implantological anchoring with minimal surgical, technical, financial and time expenditure.
Research Question:
How safe is this minimally invasive and cost-effective implant and anchoring system in terms of long-term outcome? Are the two implant-prosthetic procedures (immediate versus late restoration) different in terms of implant survival time?
Materials and methods
Enrollment:
* 20 patients without relevant pre-existing conditions, from the age of 60 years
* edentulous mandible, alveolar ridge atrophy
Statistical Analysis:
When planning the study, it is estimated that bone resorption in the peri-implant area of the immediate-care implants is greater than in the late-treated implants. 10 patients per group are required with a t-test (α = 0.05) and a power of 80% if the null hypothesis is formulated as follows: -difference of means is 0 and the alternative - expected difference of means is 1mm, common standard deviation is 0.75.
Collective A (open healing - immediate loading): Insertion of a new, prefabricated total mandibular prosthesis on the day of the operation immediately postoperatively after screwing in the Locator® abutments.
Polymerization of the corresponding Locator® matrices in the newly incorporated lower jaw denture in the patient's mouth.
Collective B (closed implant healing - conventional loading): 3 months after implantation Exposure of the primary closed implants. Immediately following insertion of the prefabricated full-thickness UK prosthesis and retention by the implants using Locator® abutments.
Test parameters:
1. Intraoperative torque measurement in Ncm
2. Radiological measurement of periimplant bone height using orthopantomogram
3. 4-point measurement of peri-implant probing depth using WHO periodontal probe. The measurement is mesial, distal, buccal and lingual of the implant.
4. Measurement of bleeding on probing (parameters of peri-implant inflammation) using the WHO periodontal probe.
5. Analysis of implant stability using the Periotest® and Osstell® measuring instruments according to a standardized scheme: The strength values are performed in a measuring range consisting of a straight line through the center of the implant and the resulting 180 ° circle sector anterior to this line results. After multiple measurements (5-fold) the lowest numerical value for the Periotest® and for the RFA (Osstell®) the lowest value documented.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional loading
Loading of 4 interforaminal implants three months after surgery.
Implant placement
interforaminal placement of 2 implants
conventional loading
conventional loading with a locator retained mandibular overdenture 3 months postoperatively
Immediate Loading
Loading of 4 interforaminal implants immediately after surgery.
Implant placement
interforaminal placement of 2 implants
immediate loading
immediate loading with a locator retained mandibular overdenture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implant placement
interforaminal placement of 2 implants
immediate loading
immediate loading with a locator retained mandibular overdenture
conventional loading
conventional loading with a locator retained mandibular overdenture 3 months postoperatively
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* edentulous lower jaw with advanced atrophy
* poor fit and retention even with a new prosthesis
Exclusion Criteria
* high risk situations for implant therapy (e.g. disorders of bone metabolism due to antiresorptive therapy)
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Neoss Ltd., Harrogate, UK
UNKNOWN
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephan Acham, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of Graz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Graz
Graz, Styria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MUGraz Neoss1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.